Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/74253
Título: Outcomes and computed tomography scan follow-up of bioresorbable vascular scaffold for the percutaneous treatment of chronic total coronary artery occlusion
Autores/as: Ojeda, Soledad
Pan, Manuel
Romero, Miguel
Suárez de Lezo, Javier
Mazuelos, Francisco
Segura, Jose
Espejo, Simona
Morenate, Carmen
Blanco, Marta
Martin, Pedro 
Alfonso Medina, M.D.
Suarez de Lezo, Jose
Clasificación UNESCO: 320501 Cardiología
3314 Tecnología médica
Palabras clave: Drug-Eluting Stents
Everolimus
Recanalization
Efficacy
Intervention, et al.
Fecha de publicación: 2015
Publicación seriada: The American journal of cardiology 
Resumen: Everolimus-eluting bioresorbable vascular scaffold (BVS) implantation in chronic total occlusion (CTO) could provide theoretical advantages at follow-up compared with metallic stents. This study aimed to assess the feasibility of BVS use for the percutaneous treatment of CTO by analyzing clinical outcomes and patency at midterm follow-up. From February 2013 to June 2014, 42 patients with 46 CTOs were treated by BVS implantation. Once the guidewire reached the distal lumen, all the occluded segments were predilated. Postdilation was performed in all patients. A multislice computed tomography was scheduled for all patients at 6 months. The mean age was 58 +/- 9 years, 41 (98%) were men and 14 (33%) diabetic. The target vessel was predominantly the left anterior descending artery (22, 48%). According to the Japanese-CTO score, 21 CTOs (46%) were difficult or very difficult. Most cases were treated with an anterograde strategy (34 lesions, 74%). A hybrid procedure with a drug-eluting stent at the distal segment was the applied treatment in 7 CTOs (15%). The mean scaffold length was 43 +/- 21 nun. Technical success was achieved in 45 lesions (98%), and 1 patient (2.4%) presented a non-Q periprocedural myocardial infarction. Re-evaluation was obtained in all patients at 6 +/- 1 months. Two re-occlusions and a focal restenosis were identified. After 13 +/- 5 months of follow-up, there were 2 repeat revascularizations (4.8%). Neither death nor myocardial infarction was documented. In conclusion, BVS for CTO seems to be an interesting strategy with a high rate of technical success and low rate of cardiac events at midterm follow-up in selected patients.
URI: http://hdl.handle.net/10553/74253
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2015.02.048
Fuente: American journal of cardiology [ISSN 0002-9149], v. 115 (11), p. 1487-1493, (Junio 2015)
Colección:Artículos
Vista completa

Citas SCOPUSTM   

38
actualizado el 24-mar-2024

Citas de WEB OF SCIENCETM
Citations

36
actualizado el 25-feb-2024

Visitas

167
actualizado el 10-feb-2024

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.